No difference in disease-free survival after oral cancer resection with close tumor margins in patients with and without postoperative radiotherapy

被引:3
|
作者
Welinder, Britta Kaltoft [1 ]
Lawaetz, Mads [1 ]
Dines, Laura M. [1 ]
Homoe, Preben [1 ,2 ]
机构
[1] Univ Hosp Copenhagen, Rigshosp, Dept Otorhinolaryngol Head & Neck Surg & Audiol, Blegdamsvej 9, DK-2100 Copenhagen East, Denmark
[2] Univ Copenhagen, Zealand Univ Hosp, Dept Otorhinolaryngol & Maxillofacial Surg, Koge, Denmark
关键词
ADJUVANT RADIOTHERAPY; SURGICAL MARGIN; INTERMEDIATE RISK; PRIMARY SURGERY; RECURRENCE; QUANTIFICATION; CARCINOMA; SHRINKAGE;
D O I
10.1177/014556131809700921
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
We conducted a retrospective follow-up study to determine if adjunctive radiotherapy (RT) affected disease-free survival in patients with oral squamous cell carcinoma (SCC) who were found to have close surgical margins after tumor resection. Our study population was made up of 110 patients-72 men and 38 women, aged 30 to 94 years (median: 66) at the time of diagnosis. Their follow-up ranged from 12 days to 5.2 years (median: 3.6 yr). Of this group, 40 patients had free margins, 55 patients had close margins, and 15 had involved margins after surgery. Only 31 of these patients received postoperative RT, including 17 who had close margins. We would expect to find better postoperative local tumor control with combined surgery and RT, but we found no statistically significant difference in disease free survival between the surgery-plus-RT group and the surgery-only group (p = 0.72). We also found no significant difference in disease free survival between patients with a tumor of the floor of mouth and those with a tumor of the tongue (p = 0.34). In the study population as a whole, the disease free survival rate was 81.0% and the overall survival rate was 78.2%. Our findings support the trend toward a watch-and-wait approach before initiating postoperative RT for patients with close surgical margins. The decision should be carefully discussed between the surgeon, the oncologic radiotherapist, and the patient.
引用
收藏
页码:314 / +
页数:6
相关论文
共 50 条
  • [21] Posttreatment Surveillance in Patients with Prolonged Disease-Free Survival After Resection of Colorectal Liver Metastasis
    Boris Galjart
    Eric P. van der Stok
    Joost Rothbarth
    Dirk J. Grünhagen
    Cornelis Verhoef
    Annals of Surgical Oncology, 2016, 23 : 3999 - 4007
  • [22] Heterogeneity in disease-free survival in breast cancer patients
    Jabbari, S. Yahyazadeh
    Khodabakhshi, R.
    Gohari, M. R.
    Mortzavi, S.
    Alidoosti, A.
    Shahidi, J.
    Moradi, A.
    Bahoor, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [23] Adenocarcinoma of the urinary bladder. Does postoperative radiotherapy improve the disease-free survival?
    Zaghloul, MS
    Aziz, SA
    Nouh, A
    Saber, RA
    Mahran, TZ
    Shazely, S
    Nazmy, MS
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 124 - 124
  • [24] Tumor budding as a predictor of disease-free survival in patients with cholangiocarcinoma
    Kim, Kyung Bin
    Ahn, Ji Hyun
    Kwon, Soon Wook
    Lee, Su Ji
    Lee, Yury
    Park, Seo Young
    Kim, Ahrong
    Choi, Kyung Un
    Lee, Chang Hun
    Huh, Gi Yeong
    PATHOLOGY & ONCOLOGY RESEARCH, 2023, 29
  • [25] THE IMPACT OF LYMPHADENECTOMY ON POSTOPERATIVE MORBIDITY AND DISEASE-FREE SURVIVAL IN PATIENTS WITH ADULT OVARIAN GRANULOSA CELL TUMOR
    Erkilinc, S.
    Taylan, E.
    Volkan, K.
    Uzaldi, I.
    Can, B.
    Ilker, C.
    Temel, O.
    Karadeniz, T.
    Gokcu, M.
    Sanci, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 827 - 827
  • [26] TECHNICAL AND BIOLOGICAL FACTORS IN DISEASE-FREE SURVIVAL AFTER HEPATIC RESECTION FOR COLORECTAL-CANCER METASTASES
    CADY, B
    STONE, MD
    MCDERMOTT, WV
    JENKINS, RL
    BOTHE, A
    LAVIN, PT
    LOVETT, EJ
    STEELE, GD
    FOSTER, JH
    BARTUS, SA
    ARCHIVES OF SURGERY, 1992, 127 (05) : 561 - 569
  • [27] Disease-Free Survival after Simultaneous or Delayed Resection of Synchronous Colorectal Liver Metastasis and Primary Cancer
    Bigourdan, Jean-Marc
    Faber, Bernard
    Rayar, Michel
    Chirpaz, Emmanuel
    Boucher, Eveline
    Boudjema, Karim
    HEPATO-GASTROENTEROLOGY, 2014, 61 (132) : 1074 - 1081
  • [28] Expression of microRNA-451 is associated with disease-free survival in gastric cancer patients treated with chemoradiotherapy after gastric resection
    Bandres, E.
    Bitarte, N.
    Arias, F.
    Zarate, R.
    Agirre, X.
    Ramirez, N.
    Sola, J. J.
    Rodriguez, J.
    Garcia-Foncillas, J.
    EJC SUPPLEMENTS, 2007, 5 (04): : 90 - 90
  • [29] Prognostic value of preoperative CT features for disease-free survival in patients with primary GISTs after resection
    Arosh S. Perera Molligoda Arachchige
    Abdominal Radiology, 2023, 48 : 1840 - 1840
  • [30] Prognostic value of preoperative CT features for disease-free survival in patients with primary GISTs after resection
    Arachchige, Arosh. S. Perera Molligoda S.
    ABDOMINAL RADIOLOGY, 2023, 48 (05) : 1840 - 1840